VETOQUINOL SA ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● In a short-term perspective, the company has interesting fundamentals.
Strengths
● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 44.2 EUR in weekly data.
● Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 39.85 support.
● The company is in a robust financial situation considering its net cash and margin position.
● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
● The group usually releases upbeat results with huge surprise rates.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● For the past year, analysts have significantly revised downwards their profit estimates.
● Below the resistance at 58 EUR, the stock shows a negative configuration when looking looking at the weekly chart.
